Abstracts Archive - Page 86 of 1683 - ATC Abstracts

2022 American Transplant Congress
Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients
W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han
Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of
*Purpose: The use of immunosuppressive agents, especially glucocorticoids, are associated with increased risks of bone loss in kidney transplant recipients (KTRs). Denosumab, a potent antiresorptive…
2022 American Transplant Congress
The Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals
R. Gruessner, J. Renz, A. C. Gruessner
Medicine, SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver transplants (DDLT) that have achieved or came close to 100 years of function first in the donor…
2022 American Transplant Congress
Pulmonary Function Tests and Liver Transplantation
D. Reino¹, P. Martinez², K. Robichaux³, M. Gosselin⁴, S. Mohammed³, J. Buggs¹, A. Kumar⁵
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²University of Miami, Miami, FL, ³University of South Florida, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Liver transplant recipients have a high risk of developing postoperative pulmonary complications. Pulmonary function tests (PFTs) are expensive and often incapable of predicting patients…
2022 American Transplant Congress
The Effect of Donor-Recipient Race and Ethnicity Match on Liver Transplantation Outcome in the United States
H. Liu, C. Kaltenmeier, R. Cruz, A. M. Thompson, D. Reddy, M. D'Alesio, S. Lebowitz, E. Ashwat, S. Tohme, D. Geller, A. Tevar, C. Hughes, A. Humar, M. Molinari
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Recipient race/ethnicity (R/E) affect liver transplantation (LT) outcomes. However, the effect of donor R/E or donor-recipient R/E match is not well studied. We aimed…
2022 American Transplant Congress
Prevalence of Mycophenolate Mofetil (MMF) Discontinuation and Outcomes in Pediatric Kidney Transplants (PKTX): A PNRC Study
A. Moudgil¹, K. Sgambat¹, E. Benoit², A. Jain³, M. Seifert⁴, C. Katsoufis⁵, L. Harshman⁶, A. Mansuri⁷, M. Somers⁸
¹Nephrology, Children's National Med. Ctr., Washington, DC, ²Nephrology, Boston's Children's Hospital, Boston, MA, ³Nephrology, Wayne State University, Troy, DC, ⁴Nephrology, The University of Alabama, Birmingham, AL, ⁵Nephrology, Holtz Children's Hospital, Miami, FL, ⁶Nephrology, University of Iowa, Iowa City, IA, ⁷Nephrology, Children's Hospital of Georgia, Augusta, GA, ⁸Nephrology, Boston Children's Hospital, Boston, MA
*Purpose: MMF is discontinued in PKTX for various reasons. In this Pediatric Nephrology Research Consortium (PNRC) study, we determined prevalence and reasons for MMF discontinuation…
2022 American Transplant Congress
Dialysis Patient Perspectives on Obesity as a Barrier to Kidney Transplantation
S. S. Hingorany, A. Klassen, B. Milliron, J. Sweeting, J. Lee, R. HaileSelasse, B. Gunen, M. N. Harhay
Drexel University, Philadelphia, PA
*Purpose: Although obesity is a known barrier to kidney transplantation (KT) and associated with delayed graft function and graft loss, guidance is lacking on optimal…
2022 American Transplant Congress
Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation
V. Subramanian¹, K. Bowers², H. Kalagotla², J. Buggs¹, N. Kemmer¹, K. Dhanireddy¹
¹Transplant Institute, Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: Cardiovascular complications after liver transplantation (LTx) are a leading cause of morbidity and mortality. The goal of this study was to evaluate risk factors…
2022 American Transplant Congress
Sars-cov-2 Antibody and T Cell Response After Vaccination with or without Intensified Immunosuppression Among Pediatric Renal Transplant Recipients
H. Pizzo¹, B. Shin², P. R. Soni³, S. Nadipuram³, J. Garrison², R. Zhang², S. C. Jordan², D. Puliyanda¹
¹Pediatric Nephrology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, ³Pediatric Infectious Disease, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Recent data has shown poor antibody response to SARS-CoV-2 vaccination among adult kidney transplant (tx) recipients, with seroconversion ranging between 22%-58% after two mRNA…
2022 American Transplant Congress
Transition Program for Young Adults with Solid Organ Transplant a Single Center Protocol
H. Y. Lee
Program for Pediatric Cardiomyopathy, Heart Failure, and Cardiac Transplantation, Columbia University Irving Medical Center, New York, NY
*Purpose: The transition process for young adult solid organ transplant patient is an important clinical milestone in a transplant patient's life. Evidenced based research demonstrates…
2022 American Transplant Congress
De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding
R. J. Knight, E. A. Graviss, D. T. Nguyen, T. N. Eagar, S. G. Yi, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber
Houston Methodist Hospital, Houston, TX
*Purpose: We sought to determine the long-term outcome of renal allografts that developed de novo DSA (dnDSA) in the setting of stable renal function.*Methods: A…